Compare Manchester United PLC (MANU) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manchester United PLC vs Moderna, Inc. — how do they compare? Manchester United PLC trades at $22.08 (market cap $3.80B), while Moderna, Inc. trades at $59.72 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 6.2× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MANU | MRNA | |
|---|---|---|
Market Cap | $3.80B | $23.60B |
Sector | Media | Health |
52-Week High | $23.53 | $81.80 |
52-Week Low | $15.10 | $22.36 |
Enterprise Value | $4.72B | $19.70B |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
